№ lp_2_3_61831
File format: docx
Character count: 58946
File size: 1903 KB
Version no:
V02.00
Valid from:
18th October 2022
Review date:
1st August 2023
Expiry date:
17th October 2023
Note:
The Strategic Planning and Performance Group (SPPG) and the Public Health Agency (PHA) have developed this PGD to facilitate the delivery of the national coronavirus immunisation programme within Northern Ireland.
Organisation:
Public Health Agency
Author:
Strategic Planning and Performance Group (SPPG) and Public Health Agency (PHA)
Target Audience:
Healthcare practitioners authorised to administer the vaccine
Period of Validity:
From 18th October 2022 to 17th October 2023
Approval Date:
18th October 2022
Change History:
V01.00 to V01.07
Amendment Information:
Various updates related to patient criteria, dosing intervals, and vaccine interactions
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2022
Region / City:
Muntinlupa City, Philippines
Topic:
Vaccine procurement and administration
Document Type:
Internal report
Organization:
Alabang Hills Village Association Inc. (AHVA)
Author:
AHV Board of Directors
Target Audience:
AHVA members
Period Covered:
March 2021 – May 2022
Approval Date:
31 May 2022
Vaccine Supplier:
ICTSI Foundation (ICTSIF)
Administration Partner:
Reliance United (Unilab subsidiary)
Number of Doses Ordered:
5,000
Number of Doses Delivered to Members:
4,684
Cost per Dose:
USD 26.83
Administration Fee per Dose:
PHP 500
Exchange Rate Used:
USD/PHP 50.00
Payment Terms:
100% cash before delivery
Penalty Fee:
PHP 10,000 per day if fewer than 100 persons vaccinated
Year:
2021
Region / City:
Streator, Illinois
Country:
United States
Location:
Woodland Community Unit School District 5, 5800 E 3000 N Rd, Streator, IL
Organization:
Woodland Community Unit District No. 5; Livingston County Health Department; Illinois Department of Public Health
Document Type:
Public vaccination clinic announcement
Subject:
COVID-19 vaccination
Vaccine Type:
Moderna COVID-19 Vaccine
Target Audience:
Residents of Livingston County and neighboring counties
Event Date:
April 17, 2021
Event Time:
8:30 AM – 10:00 AM
Second Dose Date:
May 15, 2021
Registration Method:
Online registration with voucher code
Voucher Code:
LIVINGSTONCOUNTY
Contact Institution:
Woodland Community Unit District No. 5
Administrative Staff Mentioned:
Ryan McGuckin; Kristin Mangrich; Jacob Burcenski; Jordan Farris
Year:
2025
Region / City:
Victoria, Australia
Topic:
Immunisation schedule
Document Type:
Health guide
Organization / Institution:
Victorian Government, Department of Health
Author:
Victorian Government, Department of Health
Target Audience:
General public, health professionals
Period of validity:
October 2025
Date of Approval:
October 2025
Date of Changes:
None specified
Year:
2025
Region / city:
[insert local health board name]
Theme:
Vaccination
Document type:
Patient Group Direction (PGD)
Authorising organisation:
NHS Wales
Target audience:
Healthcare professionals (Registered)
Period of validity:
01 September 2025 - 31 March 2026
Approval date:
07 August 2025
Amendment date:
30 June 2025
Review date:
01 July 2026
Expiry date:
31 March 2026
Business Rules for Quality and Outcomes Framework (QOF) 2023/2024/24-25 Vaccination and Immunisation
Note:
Author
Version Date:
01/04/2023–01/04/2024
Version:
48.049.0
Year:
2023
Region / City:
England
Subject:
Quality and Outcomes Framework, Vaccination, Immunisation
Document Type:
Guidelines
Organization:
NHS England
Author:
General Practice Specification and Extraction Service (GPSES)
Target Audience:
GP Practices, GP System Suppliers, NHS England
Effective Period:
01/04/2023 – 31/03/2025
Approval Date:
01/04/2023
Amendment History Date:
01/04/2021, 01/04/2022, 01/04/2023
Supporting Documents:
Version 1.6 of the supporting information document
Reference Documents:
NHS Digital TRUD, Primary Care Domain Reference Set Portal
Year:
2018
Region / city:
Australia
Topic:
Immunisation, Hepatitis B
Document type:
Report
Agency / institution:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Chief Medical Officer
Target audience:
Healthcare professionals, policymakers
Period of validity:
Until 31 December 2019
Date of approval:
June 2018
Date of amendments:
None
Document type:
Policy template
Subject area:
Immunisation services
Topic:
Vaccine cold chain management
Intended use:
Development of local cold chain management policies
Governing authority:
Ministry of Health
Referenced standards:
National Standards for Vaccine Storage and Transportation for Immunisation Providers 2017
Referenced publications:
Immunisation Handbook
Regulatory requirement:
Cold Chain Accreditation (CCA) or Cold Chain Compliance (CCC)
Target organisations:
Immunisation providers, clinics, pharmacies, health departments
Geographical context:
New Zealand
Scope:
Vaccine storage, transportation, ordering, stock management, and equipment maintenance
Related systems:
National Immunisation Schedule, vaccine register, national cold chain audit logger
Source type:
Administrative and regulatory guidance document
Year:
2025
Region / city:
Wales
Topic:
Inactivated influenza vaccine administration
Document type:
Addendum
Organization / institution:
NHS Wales
Author:
Welsh Medicines Advice Service (WMAS)
Target audience:
Registered healthcare professionals
Period of validity:
01 September 2025 - 31 March 2026
Approval date:
05 November 2025
Review date:
01 July 2026
Version:
1.0
Approval body:
Vaccine Clinical Advisory Group (VCAG)
Expiry date:
31 March 2026
Additional references:
Welsh Government. Health circulars. Available from https://www.gov.wales/health-circulars
Note:
[accessed 22 September 2025]
Context description:
Addendum to the NHS Wales Patient Group Direction (PGD) outlining the guidelines for administering inactivated influenza vaccines for the National Immunisation Programme 2025-2026.
Year:
2025-2026
Region / city:
England, Wales
Theme:
Vaccine uptake, influenza vaccination
Document Type:
Official guidance
Organization:
UK Department of Health, UK Health Security Agency, National Health Service
Author:
Not specified
Target audience:
NHS GP practices, hospitals, healthcare organizations in England and Wales
Period of validity:
1 September 2025 – 28 February 2026
Approval date:
Not specified
Modification date:
Not specified
Note:
Contextual description
Year:
2025
Region / City:
Victoria
Topic:
Immunisation
Document Type:
Schedule
Organization:
Victorian Government
Author:
Victorian Government
Target Audience:
General public, healthcare providers, infants, children, adolescents, adults, and at-risk groups
Period of Validity:
From September 2025
Approval Date:
Not specified
Date of Amendments:
Not specified
Year:
2024
Type of document:
Practice guidelines / referral protocol
Target cohort:
Children aged 0–6 years (focus on 12- and 15-month immunisations)
Purpose:
Consistent referral process from GP to Southern Outreach Immunisation Service
Setting:
General practice (GP) and Southern Outreach Immunisation Service (OIS)
Required actions:
Pre-call/recall contact attempts (email, text, phone)
Referral trigger:
Four weeks after initial recall if no response
Overdue criteria:
12- and 15-month immunisations
Urgency criteria:
Urgent referral if background not known; referral by 17 months if unable to contact
Documentation requirements:
Record all contact attempts and rationale in PMS progress notes
Equity consideration:
OIS prioritisation based on equity lens / priority matrix
Year:
2023
Region / City:
Aotearoa New Zealand
Subject:
COVID-19 Vaccination Policy
Document Type:
Policy Statement
Organ / Institution:
Te Whatu Ora - Health New Zealand
Author:
COVID-19 Vaccine Technical Advisory Group (CV TAG), Ministry of Health
Target Audience:
Health professionals, public health officials, and citizens in eligible age groups
Period of Application:
Ongoing
Approval Date:
March 2023
Amendment Date:
March 2023
Year:
2025
Region / city:
Victoria
Topic:
Immunisation
Document type:
Government guideline
Organization:
Victorian Government
Author:
Not specified
Target audience:
General public, healthcare providers, parents, at-risk groups
Period of validity:
From April 2025
Approval date:
Not specified
Date of changes:
Not specified
Year:
2025
Region / City:
Victoria, Australia
Topic:
Respiratory Syncytial Virus (RSV) Immunisation
Document Type:
Informational Leaflet
Organ / Institution:
Victorian Government, Department of Health
Author:
Victorian Government
Target Audience:
Parents and carers of infants and young children
Period of Action:
1 April 2025 to 30 September 2025
Approval Date:
February 2025
Date of Changes:
February 2025
Contextual Description:
A government-issued informational leaflet detailing RSV, its risks to infants, and the nirsevimab immunisation, including eligibility, administration, and availability.
Year:
2025
Region / City:
Jersey
Topic:
Influenza Immunisation
Document Type:
Standard Operating Procedures
Organization:
Family Nursing & Home Care
Author:
Head of Quality and Safety in consultation with the Quality and Performance Development Nurse
Target Audience:
Staff and volunteers at Family Nursing & Home Care
Approval Date:
15/01/2025
Review Date:
1 year (changes to process possible in 2025)
Version:
2
Date of Last Changes:
January 2025
Approval Route:
Organisational Governance Approval Group (OGAG)
National reference:
CYM-24018
Local reference:
CYM-24018
Type of document:
Patient Group Direction
Vaccine:
Inactivated influenza vaccine
Programme:
National Influenza Immunisation Programme 2024–2025
Operational period:
01 September 2024 – 31 March 2025
Valid from:
01 September 2024
Review date:
01 July 2025
Expiry date:
31 March 2025
Version:
2.0
Developing organisation:
Welsh Medicines Advice Service
Health system:
NHS Wales
Geographical scope:
Wales
Legal framework:
Human Medicines Regulations 2012, Schedule 16 Part 2
Target professionals:
Registered healthcare professionals authorised under a PGD
Author:
Welsh Medicines Advice Service
Main author:
Dianne Burnett
Peer review body:
Vaccine Clinical Advisory Group
Ratifying body:
All Wales PGD Advisory Board
Date of VCAG approval:
18 July 2024
Date of ratification:
26 July 2024
Subject area:
Immunisation and vaccination policy
Clinical focus:
Seasonal influenza vaccination
Source type:
Clinical governance and medicines administration directive
Year:
2023
Region / City:
Queensland, Australia
Topic:
Public health, immunisation
Document type:
Communique
Organization:
Metro North Public Health Unit
Target audience:
Vaccine service providers and healthcare workers
Event:
Tropical Cyclone Alfred
Health advisory:
Vaccine cold chain management and tetanus vaccination guidance